RLAY

$0.00

(

+0.00%

)
Quote details

stock

Relay Therapeutics Inc

NASDAQ | RLAY

8.03

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 12, 2025)

$1.35B

Market Cap

-

P/E Ratio

-1.77

EPS

$8.70

52 Week High

$1.77

52 Week Low

HEALTHCARE

Sector

RLAY Chart

Recent Chart
Price Action

RLAY Technicals

Tags:

RLAY Earnings

Earnings Performance

RLAY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $871M
Total Current Assets $809M
Cash And Cash Equivalents At Carrying Value $124M
Cash And Short Term Investments $124M
Inventory -
Current Net Receivables -
Total Non Current Assets $62M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.3M
Intangible Assets Excluding Goodwill $2.3M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $657M
Other Current Assets $28M
Other Non Current Assets -
Total Liabilities $94M
Total Current Liabilities $51M
Current Accounts Payable $14M
Deferred Revenue -
Current Debt -
Short Term Debt $5.7M
Total Non Current Liabilities $43M
Capital Lease Obligations $49M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $49M
Other Current Liabilities $23M
Other Non Current Liabilities -
Total Shareholder Equity $778M
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $168K
Common Stock Shares Outstanding $143M

RLAY News

RLAY Profile

Relay Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming drug discovery through its innovative protein motion platform. The company specializes in targeting allosteric sites to develop novel therapeutics for patients with specific genetic mutations, particularly in oncology and other areas with significant unmet medical needs. With a robust pipeline supported by strategic collaborations, Relay Therapeutics aims to advance treatment precision and improve patient outcomes, positioning itself as a leader in the evolving landscape of personalized medicine.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
AG
-5.17%
$15.94
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CVE
+1.74%
$18.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
HL
-2.79%
$18.81
JBLU
+1.02%
$4.94
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
AG
-5.17%
$15.94
NOK
-1.41%
$6.27
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.